ENCORSTAT
DEAD

Serial Number

77767425

Owner

Oxford BioMedica plc

Attorney

Roberta S. Bren

Filing Date

Jun 24, 2009

Add to watchlist:

No watchlists yet
View on USPTO

ENCORSTAT Trademark

Serial Number: 77767425 • Registration: 4200422

ENCORSTAT is a trademark filed by Oxford BioMedica plc on June 24, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Oxford BioMedica plc (54 trademarks)

Medawar Centre, Robert Robinson Avenue
Oxford, OX4 4GA , GB

Entity Type: 03

Trademark Details

Filing Date

June 24, 2009

Registration Date

September 4, 2012

Published for Opposition

November 29, 2011

Cancellation Date

April 5, 2019

Goods & Services

Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic / angiogenic molecules, all for medical purposes in connection with the treatment of diseases of the eye; nucleic acid sequences and chemical reagents for medical purposes in connection with the treatment of diseases of the eye, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations in connection with the treatment of diseases of the eye

Enzymes for scientific and research purposes in connection with treatment of the eye; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories in connection with treatment for the eye; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research in connection with treatment for the eye; chemical reagents for use in medical science

Medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances in connection with the treatment of diseases of the eye; syringes and injectors for medical purposes in connection with the treatment of diseases of the eye

Scientific and medical research and development in connection with the treatment of diseases of the eye; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology in connection with the treatment of diseases of the eye; advisory services relating to research and development of gene therapy products all in connection with the treatment of diseases of the eye and specifically excluding analysis services

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 5, 2019 C8..
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 8, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 8, 2018 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 4, 2017 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 14, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 14, 2016 REAP
CORRECTION UNDER SECTION 7 - PROCESSED
Sep 26, 2012 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 22, 2012 APRE
TEAS SECTION 7 REQUEST RECEIVED
Sep 17, 2012 ES7R
REGISTERED-PRINCIPAL REGISTER
Sep 4, 2012 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jul 31, 2012 DP1B
NOTICE OF ALLOWANCE CANCELLED
Jul 20, 2012 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jul 20, 2012 D1BR
CORRECTED NOA E-MAILED
Feb 22, 2012 NOAC
NOTICE OF ALLOWANCE CORRECTION ENTERED
Feb 21, 2012 ICNA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 16, 2012 AITU
FAX RECEIVED
Jan 25, 2012 FAXX
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 24, 2012 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 29, 2011 NPUB
PUBLISHED FOR OPPOSITION
Nov 29, 2011 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 9, 2011 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 21, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 19, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 11, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2011 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2011 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2011 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 29, 2011 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 22, 2010 RCSC
ASSIGNED TO LIE
Oct 7, 2010 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 7, 2010 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 7, 2010 GNSL
SUSPENSION LETTER WRITTEN
Apr 7, 2010 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 17, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2009 GNRN
NON-FINAL ACTION E-MAILED
Sep 23, 2009 GNRT
NON-FINAL ACTION WRITTEN
Sep 23, 2009 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2009 DOCK
NOTICE OF PSEUDO MARK MAILED
Jun 30, 2009 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 29, 2009 NWOS
NEW APPLICATION ENTERED
Jun 27, 2009 NWAP